seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today announced a partnership with Element Biosciences Inc., developer of the Element AVITI™ System. seqWell and Element have collaborated to demonstrate multiplexed library preparation and sequencing for hundreds of samples using plexWell products with Element’s next-generation benchtop sequencer, the AVITI System. Initial results of this collaboration will be reported at the 2022 Advances in Genome Biology and Technology (AGBT) conference to be held June 6-9, 2022, in Orlando, FL.

The pairing of the two companies’ technologies promises highly efficient workflows and improved data quality across a range of demanding high-throughput sequencing applications. By combining seqWell’s plexWell technology and the Element AVITI System, users can efficiently multiplex up to 2,304 samples with seqWell’s commercially available library preparation kits and Element’s library adaptation chemistry.

seqWell’s plexWell library preparation workflow allows efficient single-tube sample pooling after the first enzymatic step, minimizing pipetting steps and reducing sample handling, all while creating balanced library pools. plexWell enables simple and scalable multiplexing of thousands of samples, reducing the need for individual library preparation or normalization.

The Element AVITI System is a benchtop DNA sequencer based on a single flow cell and reagent cartridge design offering tunable read throughput control for independently operated flow cells. This allows the user complete run control timing and scalability and provides a flexible and cost-effective platform for next-generation sequencing applications. The system can easily be integrated into existing sequencing platform workflows, streamlining sample input and data analysis.

"We are thrilled to partner with Element Biosciences as we work towards the common goal we share of creating next-generation sequencing workflows that produce high quality results faster, and with fewer steps. plexWell’s proven compatibility with the revolutionary AVITI System confirms the value that our NGS library technologies can bring to diverse high-throughput application areas such as microbial genome sequencing and demonstrates the versatility of both companies’ technologies. Based on the outstanding performance on the AVITI System seen in our collaboration with Element, we look forward to further developing commercial applications for this exciting new platform.” 

Joe Mellor, Co-founder Chief Scientific Officer at seqWell

Shawn Levy, Senior Vice President of Applications and Scientific Affairs at Element Biosciences, commented: We are very excited to partner with seqWell because the AVITI System’s outstanding performance metrics, flexibility, and cost advantages are an ideal match with seqWell’s simple, highly scalable plexWell NGS library preparation technology. plexWell’s demonstrated compatibility with the AVITI System significantly enhances the utility of both platforms in the genomics market.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Element Biosciences. (2022, June 01). seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System. News-Medical. Retrieved on November 20, 2024 from https://www.news-medical.net/news/20220601/seqWell-and-Element-Biosciences-partner-to-demonstrate-sequencing-performance-of-multiplexed-plexWell-technology-with-the-AVITI-System.aspx.

  • MLA

    Element Biosciences. "seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System". News-Medical. 20 November 2024. <https://www.news-medical.net/news/20220601/seqWell-and-Element-Biosciences-partner-to-demonstrate-sequencing-performance-of-multiplexed-plexWell-technology-with-the-AVITI-System.aspx>.

  • Chicago

    Element Biosciences. "seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System". News-Medical. https://www.news-medical.net/news/20220601/seqWell-and-Element-Biosciences-partner-to-demonstrate-sequencing-performance-of-multiplexed-plexWell-technology-with-the-AVITI-System.aspx. (accessed November 20, 2024).

  • Harvard

    Element Biosciences. 2022. seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System. News-Medical, viewed 20 November 2024, https://www.news-medical.net/news/20220601/seqWell-and-Element-Biosciences-partner-to-demonstrate-sequencing-performance-of-multiplexed-plexWell-technology-with-the-AVITI-System.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.